Clinical Trial Update: A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers [Phase 2]

View source ↗

Summary

A Phase 2 pilot study of celecoxib in patients with grade 2 or 3 uterine cancers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• CELEBREX (Celecoxib)

Snippet

Sponsor: Mark H. Einstein | Conditions: Uterine Cancer | Phase 2 | Status: TERMINATED